Categories Earnings, Health Care
Earnings Summary: A snapshot of Bio-Techne’s (TECH) Q4 2024 results
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline in profit.
- Fourth-quarter organic revenue edged up 1% to $306.1 million; net sales moved up 2% during the three months
- Earnings per share, including special items, dropped to $0.25 in Q4 from $0.47 last year; adjusted earnings declined to $0.49 per share from $0.55 in Q4 2023
- Operating income for the fourth quarter decreased 52% to $45.8 million from $94.5 million a year earlier
- Q4 operating margin declined to 15.0% from 31.4% in the prior-year quarter, hurt mainly by impairment of assets held-for-sale, restructuring, and CEO transition costs
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
